Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells

Cell Death and Differentiation

Volumn 7, Issue 9, 2000, Pages 761-772

  Sawada, M ^a   Nakashima, S ^a   Banno, Y ^a   Yamakawa, H ^a   Hayashi, K ^a   Takenaka, K ^a   Nishimura, Y ^a   Sakai, N ^a   Nozawa, Y ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2 family; Caspase; Ceramide; Glioma

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ACETYLCYSTEINE; CASPASE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; CYTOCHROME C; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; GLUTATHIONE; INTERLEUKIN 1BETA CONVERTING ENZYME; PENICILLIN G; PROTEIN BAX; PROTEIN BCL 2; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; STREPTOMYCIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; EXPOSURE; GLIOMA CELL; HUMAN; HUMAN CELL; LIPOGENESIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0033832534     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400711     Document Type: Article

References (61)

1. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes
2. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes
3. Induction of endonucleotic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
4. Induction of apoptosis (programmed cell death) in tumor cell lines by widely diverging stimuli
5. 3-induced HL-60 cell differentiation
6. Functions of ceramide coordinating cellular responses to stress
7. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
8. The central executioner of apoptosis: Multiple concentrations between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
9. Anti-immunoglobin-induced apoptosis in WEHI-231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by Bcl-X(L)
10. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway
11. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: Role of ceramide in apoptosis
12. Programmed cell death in cortical chick embryo astrocytes is associated with activation of protein kinase PK 60 and ceramide formation
13. Evidence against an early signaling role for ceramide in Fas-mediated apoptosis
14. Fas-induced apoptosis of T cells occurs independently of ceramide generation
15. Apoptotic signal of Fas is not mediated by ceramide
16. On the complexities of ceramide changes in cells undergoing apoptosis: Lack of evidence for a second messenger function in apoptosis induction
17. Ceramide second messengers and ceramide assays
18. Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells
19. Delta 9-tetrahydrocannabiol induced apoptosis in C6 glioma cells
20. ICE-like proteases in apoptosis
21. Human ICE/CED-3 protease nomenclature
22. Involvement of MACH, a novel MORT 1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
23. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling
24. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple ced-3/ICE-like cysteine proteases
25. An Apaf-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
26. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
27. Autoactivation of procaspase-9 by Apaf-1 mediated oligomerization
28. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
29. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
30. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
31. New members of Bcl-2 family and their protein partners
32. The proto-oncogene Bcl-2 and its role in regulating apoptosis
33. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
34. Bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
35. Bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy
36. Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis
37. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons
38. Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons
39. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
40. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide
41. Immediate early up-regulation of bax expression by p53 but TGF β1: A paradigm for distinct apoptotic pathways
42. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-α-induced cell death
43. Cytokine-mediated induction of ceramide production is redox-sensitive
44. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC 12 cell death
45. 16 melanoma cells
46. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
47. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells
48. TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase
49. Accumulation of glycosylceramides in multidrug-resistant cancer cells
50. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
51. P53-dependent ceramide response to genotoxic stress
52. A conserved AU-rich element in the 3' untranslated region of bcl-2mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis
53. Reactive oxygen species are downstream mediators of p53-dependent apoptosis
54. A model for p53-induced apoptosis
55. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2
56. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase
57. Molecular cloning, characterization, and expression of a novel human neutral sphingomyelinase
58. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death
59. Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein
60. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
61. Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury